[144] GILEAD SCIENCES, INC. SEC Filing

Rhea-AI Filing Summary

Form 144 filing by an insider of Gilead Sciences (GILD) reporting proposed and recent sales of common stock. The notice shows a proposed sale of 10,000 shares to be executed through Morgan Stanley Smith Barney on 09/29/2025 with an aggregate market value of $1,116,564.00. The shares were originally acquired as restricted stock on 03/01/2020. The filing also discloses three completed sales by the same person, DANIEL O'DAY, of 10,000 shares each on 06/30/2025, 07/28/2025, and 08/28/2025 for gross proceeds of $1,104,483.00, $1,139,369.00, and $1,136,300.00, respectively. The filing lists 1,240,806,916 shares outstanding for the class and identifies NASDAQ as the exchange.

Positive

• Transparent disclosure of recent and proposed insider sales including dates, amounts, and gross proceeds
• Origin of shares documented as restricted stock acquired from the issuer on 03/01/2020
• Broker identified for the proposed sale (Morgan Stanley Smith Barney) and exchange listed (NASDAQ)

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider sales totaling 40,000 shares were disclosed, including a planned 10,000-share sale; this appears to be routine liquidity activity.

The filing documents routine Section 16/Rule 144 activity by an insider identified as Daniel O'Day. Three sales in the past three months total 30,000 shares with combined gross proceeds of $3,380,152.00. A proposed sale of 10,000 shares is scheduled for 09/29/2025 with an indicated market value of $1,116,564.00. The shares were originally received as restricted stock on 03/01/2020, which suggests vesting or availability for sale rather than an open-market accumulation or divestiture tied to new information. On the face of the form there is no allegation of undisclosed material information. Impact on equity float is immaterial relative to the reported 1,240,806,916 shares outstanding.

Corporate Governance Specialist

TL;DR: Disclosure aligns with Rule 144 requirements; sales are documented and signed statements assert no undisclosed material information.

The filer certifies lack of material nonpublic information and provides transaction provenance showing acquisition as restricted stock from the issuer on 03/01/2020. The record of multiple monthly sales and a scheduled sale indicates reliance on applicable exemptions and reporting obligations. From a governance perspective, the form contains the expected attestations and broker identification (Morgan Stanley Smith Barney). There is no indication in this filing of unusual trading patterns or regulatory exceptions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	1116564.00	1240806916	09/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2020	Restricted Stock	ISSUER			10000	03/01/2020	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	08/28/2025	10000	1136300.00
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	07/28/2025	10000	1139369.00
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	06/30/2025	10000	1104483.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sales does the GILD Form 144 report show?

The filing reports three completed sales of 10,000 shares each on 06/30/2025, 07/28/2025, and 08/28/2025 and a proposed sale of 10,000 shares scheduled for 09/29/2025.

Who is the seller named in the filing for GILD?

The filing identifies the seller as DANIEL O'DAY with an address listed in Foster City, CA.

What were the gross proceeds from the recent sales disclosed?

Gross proceeds reported are $1,104,483.00 (06/30/2025), $1,139,369.00 (07/28/2025), and $1,136,300.00 (08/28/2025).

How many shares does the Form 144 propose to sell on 09/29/2025 and what is the market value?

The proposed sale is 10,000 shares with an aggregate market value of $1,116,564.00.

When and how were the shares being sold originally acquired?

The shares were acquired as restricted stock from the issuer on 03/01/2020.